Mono ovulation in women with polycystic ovary syndrome - outcomes of different therapies

Ovulation induction is the first line of treatment for in­fer­ti­lity in women diagnosed with polycystic ovary syndrome and with no other cause of infertility. Clomi­phene citrate is the most frequently used pharmacological agent. A pros­pective study was conducted to evaluate different ovu­lation induction agents (clomiphene citrate, letrozole, re­com­binant FSH) outcomes in 60 patients diagnosed with this syndrome. The study showed similar re­sults from letrozole and clomiphene citrate in ovulation in­duction and pregnancy, but recombinant FSH had the best results.